Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...

This tool allows you to determine the current value and the yield of a given amount of stock invested in the past. Fill in the amount invested or amount of the stock, as well as the purchase date, in ...

V Novartisu spodbujamo inovativnost in razvoj ter delujemo na številnih področjih. Tudi vi lahko postanete del tega, del naše zgodbe. Pridružite se naši ustvarjalni skupnosti strokovnjakov in našli ...

Prozkoumejte pracovní příležitosti ve společnosti Novartis v seznamu níže. Pro další pozice ve společnosti Novartis Gene Therapies (dříve AveXis) navštivte GTx Hledání práce. Drug Product Technologies ...

At Novartis, we innovate, develop and operate on a vast scale. You can be part of it. Join our creative community of professionals and you will find opportunities to make an unprecedented impact – on ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Bli en del av Novartis, här kan du se mer om vilka karriärmöjligheter som finns. Du kan också söka lediga tjänster hos Novartis Gene Therapies här. Chef de Produit Snr en Dermatologie H/F CDI, Full ...

Bekijk hieronder de opportuniteiten bij Novartis. Voor functies bij Novartis Gene Therapies (voorheen AveXis), ga naar GTx Career Search. Equipment Specialist (m/w/d), Kundl, Tirol, Österreich Regulär ...

Chronic spontaneous urticaria (CSU) is a serious condition that affects approximately 1.7 million people in the United States and is characterized by itchy hives, deep tissue swelling (angioedema), or ...

Explore opportunities with Novartis below.

Recibir un diagnóstico de Leucemia Mieloide Crónica (LMC), igual que de cualquier otro tipo de cáncer, puede generar un gran shock en el paciente. Recibir un diagnóstico de Leucemia Mieloide Crónica ...